194 related articles for article (PubMed ID: 15862278)
1. A homology model for human alpha-l-iduronidase: insights into human disease.
Rempel BP; Clarke LA; Withers SG
Mol Genet Metab; 2005 May; 85(1):28-37. PubMed ID: 15862278
[TBL] [Abstract][Full Text] [Related]
2. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications.
Scott HS; Bunge S; Gal A; Clarke LA; Morris CP; Hopwood JJ
Hum Mutat; 1995; 6(4):288-302. PubMed ID: 8680403
[TBL] [Abstract][Full Text] [Related]
4. alpha-L-iduronidase mutations (Q70X and P533R) associate with a severe Hurler phenotype.
Scott HS; Litjens T; Nelson PV; Brooks DA; Hopwood JJ; Morris CP
Hum Mutat; 1992; 1(4):333-9. PubMed ID: 1301941
[TBL] [Abstract][Full Text] [Related]
5. Structural and clinical implications of amino acid substitutions in α-L-iduronidase: insight into the basis of mucopolysaccharidosis type I.
Saito S; Ohno K; Maita N; Sakuraba H
Mol Genet Metab; 2014 Feb; 111(2):107-12. PubMed ID: 24480078
[TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of 19 North American mucopolysaccharidosis type I patients: identification of two additional frequent mutations.
Clarke LA; Nelson PV; Warrington CL; Morris CP; Hopwood JJ; Scott HS
Hum Mutat; 1994; 3(3):275-82. PubMed ID: 8019563
[TBL] [Abstract][Full Text] [Related]
7. Four novel mutations underlying mild or intermediate forms of alpha-L-iduronidase deficiency (MPS IS and MPS IH/S).
Tieu PT; Bach G; Matynia A; Hwang M; Neufeld EF
Hum Mutat; 1995; 6(1):55-9. PubMed ID: 7550232
[TBL] [Abstract][Full Text] [Related]
8. alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients.
Hein LK; Bawden M; Muller VJ; Sillence D; Hopwood JJ; Brooks DA
J Mol Biol; 2004 Apr; 338(3):453-62. PubMed ID: 15081804
[TBL] [Abstract][Full Text] [Related]
9. A common mutation for mucopolysaccharidosis type I associated with a severe Hurler syndrome phenotype.
Scott HS; Litjens T; Hopwood JJ; Morris CP
Hum Mutat; 1992; 1(2):103-8. PubMed ID: 1301196
[TBL] [Abstract][Full Text] [Related]
10. [Mucopolysaccharidosis type I: identification of alpha-L-iduronidase mutations in Tunisian families].
Chkioua L; Khedhiri S; Jaidane Z; Ferchichi S; Habib S; Froissart R; Bonnet V; Chaabouni M; Dandana A; Jrad T; Limem H; Maire I; Abdelhedi M; Laradi S
Arch Pediatr; 2007 Oct; 14(10):1183-9. PubMed ID: 17728118
[TBL] [Abstract][Full Text] [Related]
11. Lessons from molecular modeling human α-L-iduronidase.
Figueiredo DF; Antunes DA; Rigo MM; Mendes MF; Silva JP; Mayer FQ; Matte U; Giugliani R; Vieira GF; Sinigaglia M
J Mol Graph Model; 2014 Nov; 54():107-13. PubMed ID: 25459762
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of 85 mucopolysaccharidosis type I families: frequency of known mutations, identification of 17 novel mutations and in vitro expression of missense mutations.
Beesley CE; Meaney CA; Greenland G; Adams V; Vellodi A; Young EP; Winchester BG
Hum Genet; 2001 Nov; 109(5):503-11. PubMed ID: 11735025
[TBL] [Abstract][Full Text] [Related]
13. Rapid and accurate denaturating high performance liquid chromatography protocol for the detection of alpha-l-iduronidase mutations causing mucopolysaccharidosis type I.
Kasper DC; Iqbal F; Dvorakova L; Zeman J; Magner M; Bodamer O; Pollak A; Herkner KR; Item CB
Clin Chim Acta; 2010 Mar; 411(5-6):345-50. PubMed ID: 19954743
[TBL] [Abstract][Full Text] [Related]
14. [Mutation analysis of 11 Chinese patients with attenuated mucopolysaccharidosis type].
WANG XN; SHI HP; ZHANG WM; QIU ZQ; MENG Y; YAO FX; WEI M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Apr; 28(2):147-51. PubMed ID: 21462124
[TBL] [Abstract][Full Text] [Related]
15. c.1898C>G/p.Ser633Trp Mutation in Alpha-L-Iduronidase: Clinical and Structural Implications.
Peña-Gomar I; Jiménez-Mariscal JL; Cerón M; Rosas-Trigueros J; Reyes-López CA
Protein J; 2021 Feb; 40(1):68-77. PubMed ID: 33389473
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetics of mucopolysaccharidosis type I: mutation analysis among the patients of the former Soviet Union.
Voskoboeva EY; Krasnopolskaya XD; Mirenburg TV; Weber B; Hopwood JJ
Mol Genet Metab; 1998 Oct; 65(2):174-80. PubMed ID: 9787109
[TBL] [Abstract][Full Text] [Related]
17. Mutation c.1190-1delG/N in intron 8 and c.1708G>C/N in exon 12 not reported in the IDUA gene developed a clinical phenotype of Scheie syndrome.
Delgado Luengo WN; Miranda Contreras LE; Chávez CJ; Solis-Añez E; Cammarata-Scalisi F
Invest Clin; 2014 Dec; 55(4):365-70. PubMed ID: 25558755
[TBL] [Abstract][Full Text] [Related]
18. Prediction of neuropathology in mucopolysaccharidosis I patients.
Fuller M; Brooks DA; Evangelista M; Hein LK; Hopwood JJ; Meikle PJ
Mol Genet Metab; 2005 Jan; 84(1):18-24. PubMed ID: 15639191
[TBL] [Abstract][Full Text] [Related]
19. [A novel mutation of the alpha-L-iduronidase gene in a patient with mucopolysaccharidosis type I].
Dou W; Peng C; Zheng JK; Gu XF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):136-9. PubMed ID: 17407067
[TBL] [Abstract][Full Text] [Related]
20. Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier.
Boado RJ; Zhang Y; Zhang Y; Xia CF; Wang Y; Pardridge WM
Biotechnol Bioeng; 2008 Feb; 99(2):475-84. PubMed ID: 17680664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
